Identification of a Domain That Mediates Association of Platelet-activating Factor Acetylhydrolase with High Density Lipoprotein

This publication has 64 references indexed in Scilit:

• The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients
  Journal of Vascular Surgery, 2007
• High Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Recurrent Coronary Events in Postinfarction Patients
  Clinical Chemistry, 2006
• Lipoprotein-Associated Phospholipase A2 and Measures of Extracoronary Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
• Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target
  Current Opinion in Pharmacology, 2006
• Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis
  Journal of Lipid Research, 2005
• Thyroid Substitution Therapy Induces High-Density Lipoprotein–Associated Platelet-Activating Factor–Acetylhydrolase in Patients with Subclinical Hypothyroidism: A Potential Antiatherogenic Effect
  Thyroid®, 2005
• Association of Lipoprotein-Associated Phospholipase A ₂ Mass and Activity With Calcified Coronary Plaque in Young Adults
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
• Lipoprotein-Associated Phospholipase A ₂ , Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Systematic Screening of the LDL-PLA2Gene for Polymorphic Variants and Case-Control Analysis in Schizophrenia
  Biochemical and Biophysical Research Communications, 1997
• PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human Plasma
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995